The Faculty of Pharmaceutical Biomedical and Veterinary Sciences of the University of Antwerp is looking for a full-time postdoctoral researcher to implement analytical platforms for metabolomics/lipidomics in human matrices with the broader aim to implement these findings in exposome studies. The project will be executed at the Toxicological Centre of the University of Antwerp (TC, UA), which has extensive analytical expertise and instrumental capabilities related to human exposure assessment and human exposome. The TC has developed in-house non-targeted metabolomics and lipidomics analytical platforms based on liquid chromatography-quadrupole time-of-flight tandem mass spectrometry (LC-QTOF-MS) and gas chromatography coupled to QTOF-MS (GC-QTOF-MS) for the analysis of different biological matrices, such as cell extracts, human and animal tissues. These established platforms need to be refined and further tailored to the analysis of human biological fluids (such as blood and urine), to ensure successful implementation in various clinical and exposomics applications. In parallel, methods for targeted metabolomics/lipidomics need to be developed and validated for groups of relevant metabolites for specific clinical conditions, to enable discovery of innovative biomarkers with predictive value. This post-doctoral position aims at implementing metabolomics/lipidomics to detect molecular fingerprints by using untargeted and targeted metabolomics and big data mining approaches in phenotypically characterized patients. The outcomes of this project would be to establish targeted and non-targeted metabolomics and lipidomics platforms at UAntwerpen for human biological fluids, and to exploit their diagnostic power in clinical applications.